Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis;Correlação entre a contagem de plaquetas no sangue e o gradiente de pressão venosa hepática em pacientes cirróticos

Arquivos de Gastroenterologia

Volumn 42, Issue 1, 2005, Pages 35-40

  Dittrich, Sirlei ^a,b   De Mattos, Angelo Alves ^a   Cheinquer, Hugo ^a   De Araújo, Fernanda Branco ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD LEVEL; DISEASE CLASSIFICATION; ENDOSCOPY; FEMALE; HEPATIC VEIN; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; THROMBOCYTE COUNT; VENOUS PRESSURE;

EID: 20044385559     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032005000100009     Document Type: Article

References (50)

1. Armonis A, Patch D, Burroughs A. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis? Hepatology 1997;25:245-8.
2. Bean WB, Paul WD, Franklin M. Preliminary studies on an indirect method for determining portal pressure. J Clin Invest 1949;28:769-70.
3. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;92:1302-4.
4. Bosch J, Navasa M, Garcia-Pagán JC, Pizcueta MP, Rodés J. Portal hypertension. Med Clin North Am 1989;73:931-53.
5. Bosch J. Prevention of variceal rebleeding: endoscopes, drugs and more. Hepatology 2000;32:660-1.
6. Brazzini A, Hunter DW, Darcy MD, Smith TP, Cragg AH, Castaneda-Zuniga WR, Amplatz K. Safe splenoportography. Radiology 1987;162:607-9.
7. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, Bru C, Rodes J. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-22.
8. Burcharth F, Rasmussen SN. Localization of the porta hepatis by ultrasonic scanning prior to percutaneous transhepatic portography. Br J Surg 1974;47:598-602.
9. Burcharth F, Joyce F. Percutaneous transhepatic catheterization of the portal venous system. J Gastroenterol Hepatol 1987;2:569-87.
10. D'amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-48.
11. Darcy MD, Kanterman RY, Kleinhoffer MA, Vesely TM, Picus D, Hicks ME, Pilgram TK. Evaluation of coagulation tests as predictors of angiographic bleeding complications. Radiology 1996;198:741-4.
12. De Francis R. Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-52.
13. De Noronha R, Taylor BA, Wild G,Triger DR, Greaves M. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and the severity of liver disease. Clin Lab Haematol 1991;13:127-35.
14. Fenyves D, Pomie-Layrargues G, Willems B, Côté J. Intrahepatic pressure measurement: not an accurate reflection of portal vein pressure. Hepatology 1988;8:211-6.
15. Garcia-Tsao G, Groszmann RJ, Fischer RL, Conn HO, Atterbury CE, Glickman M. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419-24.
16. George JN. Platelets. Lancet 2000;355:1531-9.
17. Gertsch P, Fischer G, Kleber G. Manometry of esophageal varices: comparison of an endoscopic baloon technique with needle puncture. Gastroenterology 1993;105:1159-66.
18. Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, Bosch J, Stiegmann GV, Henderson JM, De Franchis R, Wagner JL, Conn HO, Rodes J. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998;28:868-80.
19. Groszmann RJ, Glickman M, Blei AT, Storer E, Conn HO. Wedged and free hepatic vein venous pressure measured with balloon catheter. Gastroenterology 1975;76:253-8.
20. Groszmann RJ, Atterbury LE. The pathophysiology of portal hypertension: a basis for classification. Semin Liver Dis 1982;2:217-86.
21. Kawasaki T, Takeshita A, Souda K, Kobayashi Y, Kikuyama M, Suzuki F, Kageyama F, Sasada Y, Shimisu E, Murohisa G, Koide S, Yoshimi T, Nakamura H, Ohno R. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol 1999;94:1918-22.
22. Kitanok T, Shimodaira S, Ito T. Liver cirrhosis with marked thrombocytopenia and highly evaluated serum thrombocytopenia levels. Int J Hematol 1999;70:52-5.
23. Le Moine O, Hadengue A, Moreau R, Sogni P, Soupison T, Yang S, Hartleb M, Lebrec D. Relationship between portal pressure, esophageal varices, and variceal bleeding on basis of stage and cause of cirrhosis. Scand J Gastroenterol 1997;32:731-5.
24. Lebrec D, Benhamou JP. Noncirrhotic intrahepatic portal hypertension. Semin Liver Dis 1986;6:332-40.
25. Lechner K, Niessner H, Thaler E. Coagulation abnormalities in liver disease. Semin Thromb Hemost 1977;4:40-56.
26. rd edition. London: Saunders; 1992. p. 1296-322.
27. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, Sacerdoti D, Angeli P, Gatta A. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992;102:973-9.
28. Myers JD, Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest 1951;30:662-3.
29. The North Italian Endoscopic Club for Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med 1988;319:983-9.
30. Okuda K, Takayasu K, Iwamoto S. Angiography in the diagnosis of the liver disease. Semin Liver Dis 1989;9:50-62.
31. Pascal JP, Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856-61.
32. Peck-Radosavlievic M, Zacherl J, Meng YG, Pidlich J, Lipinski E, Langle F, Steininger R, Muhlbacher F, Gangl A. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997;27:127-31.
33. Peck-Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 2000;14 (Suppl D):60D-6D.
34. Poynard T, Bedossa P. Age and platelets count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. Metavir and Clinivir Cooperative Study Groups. J Viral Hepat 1997;4:199-208.
35. Pugh RN, Murray-Lyon IM, Dawson JL. Transection of the oesophagus of bleeding oesophageal varices. Br J Surg 1973;60:646-9.
36. Sabbá C, Merkel C, Zoli M. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program. Hepatology 1995;21:428-33.
37. Schepis F, Cammà C, Niceforo D. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001;33:333-8.
38. th ed. Oxford: Blackwell Science; c1997. p. 135-80.
39. Shimodaira S, Ishida F, Ishikawa N, Tahara T, Kato T, Kodaira H, Ito T, Tanaka E, Sodeyama T, Kiyosawa K, Kitano K. Serum thrombopoietin (c - Mpl Ligand) levels in patients with liver cirrhosis. Thromb Haemost 1996;76:545-8.
40. Siringo S, Bolondi L, Gaiani S. Timing of the first variceal hemorrhage in cirrhotic patients: prospective evaluation of Doppler flowmetry, endoscopy and clinical parameters. Hepatology 1994;20:66-73.
41. Stanley AJ, Robinson I, Forrest EH, Jones AL, Hayes PC. Haemodynamic parameters predicting variceal haemorrhage and survival in alcoholic cirrhosis. Q J Med 1998;91:19-25.
42. Taylor WJ, Myers JD. Occlusive hepatic venous catheterization in the study of the normal liver, cirrhosis of the liver and noncirrhotic portal hypertension. Circulation 1956;13:368-80.
43. Thomopoulos KC, Labrapoulou-Karatza C, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis 2003;35:473-8.
44. Viallet A, Marleau D, Huet M. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975;69:1297-300.
45. Villanueva C, Miñana J, Ortiz J, Gallego A, Soriano G, Torras X, Sainz S, Boadas J, Cusso X, Guarner C, Balanzo J. Endoscopic compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647-55.
46. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, Morel I, Audano M, Tanno H, Lerner E, Passamonti M. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10 years prospective study. Gastroenterology 1996;111:701-9.
47. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok ASF. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-26.
48. Westaby S, Wikinson SP, Warren R, Williams R. Spleen size and portal hypertension in cirrhosis. Digestion 1978;17:63-8.
49. Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 1999;94:3292-6.
50. Zoli M, Iervese T, Bellon S, Merkel C. Prognostic significance of portal hemodynamics in patients with compensated cirrhosis. J Hepatol 1993;17:56-61.